Exenatide Microspheres
Brand names: Bydureon Bcise
Part of: GLP-1 drugs
At a glance
- Medicare prescriptions, 2024
- 84,591
- Medicare drug cost
- $88.5M
- Average cost per prescription
- $1,046
- Clinicians who prescribed it
- 4,798
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
Exenatide injection is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
From the FDA-approved prescribing information (label dated May 2026). Full labels on DailyMed (opens in a new tab)
Who prescribes it
- Family Medicine 36.3%
- Internal Medicine 24.5%
- Nurse Practitioners 15.2%
- Endocrinology & Diabetes 14.5%
- Physician Assistants 5.4%
- Geriatric Medicine 1.3%
- General Practice 0.9%
- Nephrology (Kidney) 0.3%
- Cardiology 0.2%
- Hospitalist 0.2%
- Pulmonology 0.1%
- Psychiatric Nurse Practitioners 0.1%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions fell 65% from 2019 to 2024.
Biggest change by state since 2019
- New Jersey −8%
- Minnesota −17%
- Washington −20%
- Massachusetts −39%
- Virginia −56%
- Georgia (smallest change) −78%
- Mississippi (smallest change) −77%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
Industry payments about this drug
No industry payments to clinicians named this drug in 2025.
Recalls and shortages
Not on the FDA drug shortage list.
1 recall since 2020
- Aug 2026 · Amneal Pharmaceuticals of New York, LLC · Class II
Defective Delivery System: Possibility of no medication in the prefilled pen.
Recalls usually affect specific lots from one maker, not every version of a drug. Class I is the most serious; most drug recalls are Class II. FDA recalls (opens in a new tab)
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.